Nuveen
ACTU icon

Nuveen’s Actuate Therapeutics ACTU Stock Holding History

Nuveen’s Portfolio ACTU Stock Details ACTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$9.7K Buy
+6,146
New +$7.38K ﹤0.01% 4558

Other funds holding ACTU

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Texas Capital Bank Wealth Management Services
Texas Capital Bank Wealth Management Services Dallas, Texas $1.94B AUM 19.18% 1-Year Est. Return
Rock Creek Group
Rock Creek Group Washington, District of Columbia $1.04B AUM 6.61% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $106B AUM 21.33% 1-Year Est. Return
Gleason Group
Gleason Group Prospect, Kentucky $1.13B AUM 12.68% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Sowell Financial Services
Sowell Financial Services North Little Rock, Arkansas $3.12B AUM 22.73% 1-Year Est. Return
GRWP
Green Ridge Wealth Planning Montville, New Jersey $249M AUM 26.89% 1-Year Est. Return
FNY Investment Advisers
FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return
Global Retirement Partners
Global Retirement Partners San Rafael, California $7.1B AUM

Nuveen's ACTU Position: Q3 2026 in Review

Nuveen opened a new position in Actuate Therapeutics (ACTU) in Q3 2026: 6,146 shares worth $9.7K. The stake represents ﹤0.01% of the portfolio and ranks #4558 among its holdings.

18 funds tracked by Wall St. Rank hold ACTU as of Q3 2026.

  • Nuveen held 6,146 shares of Actuate Therapeutics worth $9.7K as of Q3 2026.
  • Actuate Therapeutics was a new Nuveen position in Q3 2026.
  • Actuate Therapeutics made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #4558 holding.
  • 18 funds tracked by Wall St. Rank held Actuate Therapeutics as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.